Industry: Chemical & Material
Published Date: 2026-04-18
Pages: 135 Pages
Report ld: 6483772
Request Sample
Customized Report
Riboflavin Kinase Market Size(US$)

CAGR 2026-2032
6.5%
Market Size,2032
USD 1,307
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Riboflavin Kinase market was valued at US$ 846 million in 2025 and is anticipated to reach US$ 1307 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Riboflavin Kinase competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Riboflavin Kinase is a vitamin that is needed for growth and overall good health. It helps the body break down carbohydrates, proteins and fats to produce energy, and it allows oxygen to be used by the body. In enzymology, Riboflavin Kinase is an enzyme that works as catalysis for ATP. Riboflavin is known as Vitamin B2 and is converted into flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) by riboflavin kinase and FMN adenylyltransferase, respectively.
According to our Wellness & Health Research Center, the global wellness & health economy was valued at US dollars 4.8 trillion. Asia Pacific was the region with the highest spending on big health in 2022, with a total spending of $1.68 trillion, followed by North America ($1.42 trillion) and Europe ($1.0 trillion). According to the health industry accounting analysis data disclosed by the Health Development Research Center of the National Health Commission, from 2019 to 2021, the market size of the health service industry grew by an average of 7.0% per year, and the specific data increased from 7.7 trillion yuan to 8.8 trillion yuan. China"s health industry revenue reached 8.0 trillion yuan in 2021, with an increase of 8.1%.
This report delivers a comprehensive overview of the global Riboflavin Kinase market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Riboflavin Kinase. The Riboflavin Kinase market size, estimates, and forecasts are provided in terms of output/shipments (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Riboflavin Kinase market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Riboflavin Kinase manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Riboflavin Kinase manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Riboflavin Kinase production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Riboflavin Kinase consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Riboflavin Kinase Market Overview
1.1 Product Definition
1.2 Riboflavin Kinase by Type
1.2.1 Global Riboflavin Kinase Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Feed Grade
1.2.3 Food Grade
1.2.4 Pharma Grade
1.3 Riboflavin Kinase by Application
1.3.1 Global Riboflavin Kinase Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Food Additives
1.3.3 Animal Feeding
1.3.4 Pharmaceutical
1.3.5 Health Supplements
1.3.6 Cosmetic And Personal Care
1.3.7 Others
1.4 Global Market Growth Prospects
1.4.1 Global Riboflavin Kinase Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Riboflavin Kinase Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Riboflavin Kinase Production Estimates and Forecasts (2021–2032)
1.4.4 Global Riboflavin Kinase Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Riboflavin Kinase Production Market Share by Manufacturers (2021–2026)
2.2 Global Riboflavin Kinase Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Riboflavin Kinase, Industry Ranking, 2024 vs 2025
2.4 Global Riboflavin Kinase Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Riboflavin Kinase Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Riboflavin Kinase, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Riboflavin Kinase, Product Offerings and Applications
2.8 Global Key Manufacturers of Riboflavin Kinase, Date of Entry into the Industry
2.9 Riboflavin Kinase Market Competitive Situation and Trends
2.9.1 Riboflavin Kinase Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Riboflavin Kinase Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Riboflavin Kinase Production by Region
3.1 Global Riboflavin Kinase Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Riboflavin Kinase Production Value by Region (2021–2032)
3.2.1 Global Riboflavin Kinase Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Riboflavin Kinase by Region (2027–2032)
3.3 Global Riboflavin Kinase Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Riboflavin Kinase Production Volume by Region (2021–2032)
3.4.1 Global Riboflavin Kinase Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Riboflavin Kinase by Region (2027–2032)
3.5 Global Riboflavin Kinase Market Price Analysis by Region (2021–2032)
3.6 Global Riboflavin Kinase Production, Value, and Year-over-Year Growth
3.6.1 North America Riboflavin Kinase Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Riboflavin Kinase Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Riboflavin Kinase Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Riboflavin Kinase Production Value Estimates and Forecasts (2021–2032)
4 Riboflavin Kinase Consumption by Region
4.1 Global Riboflavin Kinase Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Riboflavin Kinase Consumption by Region (2021–2032)
4.2.1 Global Riboflavin Kinase Consumption by Region (2021–2026)
4.2.2 Global Riboflavin Kinase Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Riboflavin Kinase Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Riboflavin Kinase Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Riboflavin Kinase Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Riboflavin Kinase Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Riboflavin Kinase Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Riboflavin Kinase Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Riboflavin Kinase Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Riboflavin Kinase Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Riboflavin Kinase Production by Type (2021–2032)
5.1.1 Global Riboflavin Kinase Production by Type (2021–2026)
5.1.2 Global Riboflavin Kinase Production by Type (2027–2032)
5.1.3 Global Riboflavin Kinase Production Market Share by Type (2021–2032)
5.2 Global Riboflavin Kinase Production Value by Type (2021–2032)
5.2.1 Global Riboflavin Kinase Production Value by Type (2021–2026)
5.2.2 Global Riboflavin Kinase Production Value by Type (2027–2032)
5.2.3 Global Riboflavin Kinase Production Value Market Share by Type (2021–2032)
5.3 Global Riboflavin Kinase Price by Type (2021–2032)
6 Segment by Application
6.1 Global Riboflavin Kinase Production by Application (2021–2032)
6.1.1 Global Riboflavin Kinase Production by Application (2021–2026)
6.1.2 Global Riboflavin Kinase Production by Application (2027–2032)
6.1.3 Global Riboflavin Kinase Production Market Share by Application (2021–2032)
6.2 Global Riboflavin Kinase Production Value by Application (2021–2032)
6.2.1 Global Riboflavin Kinase Production Value by Application (2021–2026)
6.2.2 Global Riboflavin Kinase Production Value by Application (2027–2032)
6.2.3 Global Riboflavin Kinase Production Value Market Share by Application (2021–2032)
6.3 Global Riboflavin Kinase Price by Application (2021–2032)
7 Key Companies Profiled
7.1 DSM
7.1.1 DSM Riboflavin Kinase Company Information
7.1.2 DSM Riboflavin Kinase Product Portfolio
7.1.3 DSM Riboflavin Kinase Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 DSM Main Business and Markets Served
7.1.5 DSM Recent Developments/Updates
7.2 BASF
7.2.1 BASF Riboflavin Kinase Company Information
7.2.2 BASF Riboflavin Kinase Product Portfolio
7.2.3 BASF Riboflavin Kinase Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 BASF Main Business and Markets Served
7.2.5 BASF Recent Developments/Updates
7.3 NB Group
7.3.1 NB Group Riboflavin Kinase Company Information
7.3.2 NB Group Riboflavin Kinase Product Portfolio
7.3.3 NB Group Riboflavin Kinase Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 NB Group Main Business and Markets Served
7.3.5 NB Group Recent Developments/Updates
7.4 Shanghai Acebright Pharmaceuticals
7.4.1 Shanghai Acebright Pharmaceuticals Riboflavin Kinase Company Information
7.4.2 Shanghai Acebright Pharmaceuticals Riboflavin Kinase Product Portfolio
7.4.3 Shanghai Acebright Pharmaceuticals Riboflavin Kinase Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Shanghai Acebright Pharmaceuticals Main Business and Markets Served
7.4.5 Shanghai Acebright Pharmaceuticals Recent Developments/Updates
7.5 Hubei Guangji Pharmaceutical
7.5.1 Hubei Guangji Pharmaceutical Riboflavin Kinase Company Information
7.5.2 Hubei Guangji Pharmaceutical Riboflavin Kinase Product Portfolio
7.5.3 Hubei Guangji Pharmaceutical Riboflavin Kinase Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Hubei Guangji Pharmaceutical Main Business and Markets Served
7.5.5 Hubei Guangji Pharmaceutical Recent Developments/Updates
7.6 Ningxia Qiyuan Pharma
7.6.1 Ningxia Qiyuan Pharma Riboflavin Kinase Company Information
7.6.2 Ningxia Qiyuan Pharma Riboflavin Kinase Product Portfolio
7.6.3 Ningxia Qiyuan Pharma Riboflavin Kinase Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Ningxia Qiyuan Pharma Main Business and Markets Served
7.6.5 Ningxia Qiyuan Pharma Recent Developments/Updates
7.7 Hebei Shengxue Dacheng
7.7.1 Hebei Shengxue Dacheng Riboflavin Kinase Company Information
7.7.2 Hebei Shengxue Dacheng Riboflavin Kinase Product Portfolio
7.7.3 Hebei Shengxue Dacheng Riboflavin Kinase Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Hebei Shengxue Dacheng Main Business and Markets Served
7.7.5 Hebei Shengxue Dacheng Recent Developments/Updates
7.8 Xinfa Pharmaceutical
7.8.1 Xinfa Pharmaceutical Riboflavin Kinase Company Information
7.8.2 Xinfa Pharmaceutical Riboflavin Kinase Product Portfolio
7.8.3 Xinfa Pharmaceutical Riboflavin Kinase Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Xinfa Pharmaceutical Main Business and Markets Served
7.8.5 Xinfa Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Riboflavin Kinase Industry Chain Analysis
8.2 Riboflavin Kinase Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Riboflavin Kinase Production Modes and Processes
8.4 Riboflavin Kinase Sales and Marketing
8.4.1 Riboflavin Kinase Sales Channels
8.4.2 Riboflavin Kinase Distributors
8.5 Riboflavin Kinase Customer Analysis
9 Riboflavin Kinase Market Dynamics
9.1 Riboflavin Kinase Industry Trends
9.2 Riboflavin Kinase Market Drivers
9.3 Riboflavin Kinase Market Challenges
9.4 Riboflavin Kinase Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Riboflavin Kinase was estimated to be worth US$ 846 million in 2025 and is projected to reach US$ 1307 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 135
USD 3950.00
(Single User License)
The global Riboflavin Kinase market size was US$ 799 million in 2024 and is forecast to a readjusted size of US$ 1234 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published Date: 2025-11-10
Pages: 80
USD 4250.00
(Single User License)
The global Riboflavin Kinase market is projected to grow from US$ 799 million in 2024 to US$ 1234 million by 2031, at a CAGR of 6.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-08
Pages: 140
USD 4900.00
(Single User License)
The global market for Riboflavin Kinase was estimated to be worth US$ 799 million in 2024 and is forecast to a readjusted size of US$ 1234 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 96
USD 3950.00
(Single User License)
The global market for Riboflavin Kinase was valued at US$ 799 million in the year 2024 and is projected to reach a revised size of US$ 1234 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published Date: 2025-01-13
Pages: 92
USD 2900.00
(Single User License)
Riboflavin Kinase is a vitamin that is needed for growth and overall good health. It helps the body break down carbohydrates, proteins and fats to produce energy, and it allows oxygen to be used by the body. In enzymology, Riboflavin Kinase is an enzyme that works as catalysis for ATP. Riboflavin is known as Vitamin B2 and is converted into flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) by riboflavin kinase and FMN adenylyltransferase, respectively.
Published Date: 2024-04-10
Pages: 87
USD 4900.00
(Single User License)
Riboflavin Kinase is a vitamin that is needed for growth and overall good health. It helps the body break down carbohydrates, proteins and fats to produce energy, and it allows oxygen to be used by the body. In enzymology, Riboflavin Kinase is an enzyme that works as catalysis for ATP. Riboflavin is known as Vitamin B2 and is converted into flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) by riboflavin kinase and FMN adenylyltransferase, respectively.
Published Date: 2024-01-17
Pages: 90
USD 2900.00
(Single User License)
The global market for Riboflavin Kinase was estimated to be worth US$ 846 million in 2025 and is projected to reach US$ 1307 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-06-16
Pages: 135
The global Riboflavin Kinase market size was US$ 799 million in 2024 and is forecast to a readjusted size of US$ 1234 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published: 2025-11-10
Pages: 80
The global Riboflavin Kinase market is projected to grow from US$ 799 million in 2024 to US$ 1234 million by 2031, at a CAGR of 6.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-08
Pages: 140
The global market for Riboflavin Kinase was estimated to be worth US$ 799 million in 2024 and is forecast to a readjusted size of US$ 1234 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 96
The global market for Riboflavin Kinase was valued at US$ 799 million in the year 2024 and is projected to reach a revised size of US$ 1234 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published: 2025-01-13
Pages: 92
Riboflavin Kinase is a vitamin that is needed for growth and overall good health. It helps the body break down carbohydrates, proteins and fats to produce energy, and it allows oxygen to be used by the body. In enzymology, Riboflavin Kinase is an enzyme that works as catalysis for ATP. Riboflavin is known as Vitamin B2 and is converted into flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) by riboflavin kinase and FMN adenylyltransferase, respectively.
Published: 2024-04-10
Pages: 87
Riboflavin Kinase is a vitamin that is needed for growth and overall good health. It helps the body break down carbohydrates, proteins and fats to produce energy, and it allows oxygen to be used by the body. In enzymology, Riboflavin Kinase is an enzyme that works as catalysis for ATP. Riboflavin is known as Vitamin B2 and is converted into flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) by riboflavin kinase and FMN adenylyltransferase, respectively.
Published: 2024-01-17
Pages: 90
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now